Fundai

Razak Pharmaceutical Company (DRAZAK) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DRAZAK
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Cash generated from operations3,552,6305,931,1011,717,4312,152,1661,673,009-497,460
Cash payments for income tax-90,586-124,792-128,797-408,573-103,6760
Net cash inflow (outflow) from operating activities3,462,0445,806,3091,588,6341,743,5931,569,333-497,460
Cash payments for purchase of property, plant and equipment-83,139-3,178-449-7,386-32,749-168,480
Cash receipts from dividends786,679664,85216040,19661307,947
Cash receipts from interest on other investments1,2711,1963,64330,9775,200374
Net cash inflow (outflow) from investing activities704,811662,8703,35460,953-44,180137,956
Net cash inflow (outflow) before financing activities4,166,8556,469,1791,591,9881,804,5461,525,153-359,504
Cash receipts from facilities1,487,3743,000,5641,000,0003,663,3725,791,9107,037,764
Cash payments for principal of loans-3,600,621-5,713,490-407,328-4,228,754-5,689,360-5,603,957
Cash payments for interest on loans-1,216,973-2,807,067-768,646-781,618-741,091-615,516
Cash payments for dividends-222,160-652,643-1,400,402-312,686-69,961-553,298
Net cash inflow (outflow) from financing activities-3,552,380-6,172,636-1,576,376-1,656,280-653,206296,613
Net increase (decrease) in cash614,475296,54315,612148,266871,947-62,891
Cash balance at beginning of year327,6963,14820,914117,510135,193157,059
Cash balance at end of year942,171299,84236,526265,7761,008,12094,168
Non-cash transactions-157,29100000

Reporting periods

78 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.